4//SEC Filing
SYNBIOTICS CORP 4
Accession 0001181431-04-044957
CIK 0000719483operating
Filed
Sep 26, 8:00 PM ET
Accepted
Sep 27, 2:14 PM ET
Size
14.8 KB
Accession
0001181431-04-044957
Insider Transaction Report
Form 4
SYNBIOTICS CORPSBIO
DONELAN THOMAS A
Director10% Owner
Transactions
- Other
Common Stock Warrant
2004-09-23+250,000→ 250,000 total(indirect: By LLC)Exercise: $0.17From: 2004-09-23Exp: 2010-09-01→ Common Stock (250,000 underlying) - Purchase
Series C Preferred Stock
2004-09-23$1000.00/sh+100$100,000→ 778,452 total(indirect: By LLC)→ Common Stock (778,452 underlying)
Holdings
- 332,213
Common Stock
- 21,796,668(indirect: By LLC)
Series C Preferred Stock
→ Common Stock (21,796,668 underlying) - 712,866(indirect: By LLC)
Common Stock
Footnotes (4)
- [F1]Acquired pursuant to the election of Redwood West Coast, LLC in lieu of cash dividends on Synbiotics Corporation's Series C Preferred Stock held by Redwood West Coast, LLC, as permitted by the Certificate of Determination of the Series C Preferred Stock of Synbiotics Corporation. As required by its Operating Agreement, Redwood West Coast, LLC directed that the shares of Common Stock be issued directly to its members. Redwood Holdings, LLC received 712,866 shares of Common Stock of Synbiotics Corporation in these distributions. Redwood Holdings, LLC is the owner of record of 712,866 shares of Common Stock of Synbiotics Corporation. Mr. Donelan is a 24.9% owner of Redwood Holdings, LLC, which has sole voting and dispositive power with respect to the shares. Mr. Donelan disclaims beneficial ownership of the shares reflected above, except to the extent of his direct pecuniary interest in Redwood Holdings, LLC.
- [F2]See Exhibit 99.1 to this Form 4.
- [F3]On September 23, 2004, Redwood Holdings, LLC purchased 100 shares of Series C Convertible Preferred Stock of Synbiotics Corporation. Redwood Holdings, LLC is the beneficial owner of 100 shares of Series C Convertible Preferred Stock of Synbiotics Corporation. Mr. Donelan is a 24.9% owner of Redwood Holdings, LLC. In addition, Mr. Donelan serves on the Management Committee of Redwood Holdings, LLC, which has sole voting and dispositive power with respect to the shares. The shares are convertible into shares of common stock at any time into such number of shares of common stock by dividing each share of Series C Convertible Preferred Stock, valued at $1,000, by the conversion price - initially set at $0.12846. Mr. Donelan disclaims beneficial ownership of the shares reflected above, except to the extent of his direct pecuniary interest in Redwood Holdings, LLC.
- [F4]On September 23, 2004, in conjunction with a credit agreement, Remington Capital, LLC received a warrant to purchase 250,000 shares of Common Stock of Synbiotics Corporation with an exercise price of $0.17 per share. The warrant is exercisable at any time, in whole or in part, through September 1, 2010. Remington Capital, LLC is indirectly owned 100% by Redwood Holdings, LLC. Mr. Donelan is a 24.9% owner of Redwood Holdings, LLC. Mr. Donelan disclaims beneficial ownership of the shares reflected above, except to the extent of his direct pecuniary interest in Redwood Holdings, LLC.
Documents
Issuer
SYNBIOTICS CORP
CIK 0000719483
Entity typeoperating
IncorporatedCA
Related Parties
1- filerCIK 0000719483
Filing Metadata
- Form type
- 4
- Filed
- Sep 26, 8:00 PM ET
- Accepted
- Sep 27, 2:14 PM ET
- Size
- 14.8 KB